Drugs / Isoflavone supplement
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT00179556 | Jun 2003 → Jul 2005 | — | Beth Israel Deaconess Medical Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Isoflavone supplement | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00179556 ↗ |
| Known as | Agly-Max TM | “This isoflavone-aglycone extract (Agly-Max TM, Nichimo, Shinagawa, Tokyo, Japan) is a product prepared from soybean germ fermentation with Koji fungus” NCT00179556 ↗ |